南亚癌症差异的交织性:呼吁公平防控议程
贫困、薄弱基础设施与性别、种姓、宗教、语言、地理及性少数身份等交织加剧不公平。文章基于针对性文献,提出以交织性为导向的议程:加强登记与 disaggregated 数据、公平筹资与人力部署、文化能力培训及交叉风险建模研究。
要点
- 南亚癌症差异由贫困、基础设施薄弱与多重身份交织驱动。
- 女性因HPV疫苗接种和筛查低覆盖而诊断延迟。
- 农村社区面临距离与费用障碍,达利特、原住民和难民遭结构性排斥。
核心结论
- 南亚癌症差异是多重身份交织的结果,需采取交织性知情议程以实现公平防控。
研究设计与样本
- 基于SAARC国家针对性文献的综述性论述,未报告系统检索范围与样本量。
主要发现
- 女性因HPV疫苗接种和筛查低覆盖而诊断延迟。
- 农村社区面临距离与费用障碍。
- 达利特、原住民和难民群体经历结构性排斥。
- 语言不一致与文化信念阻碍及时诊疗。
- 财务毒性普遍,即使新兴保险计划仍使家庭陷入贫困。
临床怎么用
- 加强癌症登记与国家癌症控制规划,使用 disaggregated 数据。
- 扩大公平筹资与 workforce 部署。
- 在临床培训中嵌入文化能力与偏见缓解。
- 优先开展模拟交叉风险的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Member states of the South Asian Association for Regional Cooperation (SAARC), home to over 2 billion people, carry a disproportionate cancer burden shaped by stark heterogeneity in risk, access, and outcomes. Beyond large proportions of people living in poverty in the context of frail infrastructure, inequities are compounded by intersecting identities, including gender, caste, religion, language, geography, and sexual or gender minority status. Commonly, women face delayed diagnosis amid low human papillomavirus vaccination and screening; rural communities confront distance and cost; Dalit, indigenous, and refugee groups experience structural exclusion; and language discordance and cultural beliefs impede timely care. Financial toxicity is pervasive, pushing households into poverty despite emerging insurance schemes. Drawing on targeted literature from SAARC countries, we argue for an intersectionality-informed agenda: strengthen registries and national cancer control programmes with disaggregated data; expand equitable financing and workforce deployment; embed cultural competence and bias mitigation in clinical training; and prioritise research that models intersecting risks. Implementing context-appropriate strategies will be essential for achieving equitable cancer control across the region.
引用
- Menon TP, Mathew A, Iyengar P, et al. Intersectionality of cancer disparities in south Asia. Lancet Glob Health. 2026. PMID: 41519156. doi:10.1016/S2214-109X(25)00444-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。